CRP and non-Hodgkin lymphoma: Based on many recent studies, it is now widely accepted that an elevated CRP value is a reliable indicator of poor prognosis for certain malignant tumors including melanoma, non-Hodgkin's lymphoma, colorectal, lung, prostate and ovary [12,15,16].